MeiraGTx Holdings plc (MGTX) stock
MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3064% below fair value
$8.46−0.28 (-3.20%)
Close on Nov 17, 2026Market cap $812.52MP/E 11.9Yield –
MeiraGTx operating margin
Operating margin is operating income as a percentage of revenue.
MeiraGTx's operating margin for the twelve months ending Jun 30, 2026 was 46.3%. For fiscal 2025 it was -130.2%, against -493.4% the year before. The highest annual figure on record is -130.2% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -130.2% | +363.2 |
| FY2024 | Dec 31, 2024 | -493.4% | +484.4 |
| FY2023 | Dec 31, 2023 | -977.8% | −246.9 |
| FY2022 | Dec 31, 2022 | -730.9% | −537.9 |
| FY2021 | Dec 31, 2021 | -193.0% | +209.0 |
| FY2020 | Dec 31, 2020 | -401.9% | +36.4 |
| FY2019 | Dec 31, 2019 | -438.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 76.0% | +1289.6 |
| Q1 FY2026 | Mar 31, 2026 | -13930.7% | −11771.0 |
| Q4 FY2025 | Dec 31, 2025 | 35.1% | +182.3 |
| Q3 FY2025 | Sep 30, 2025 | -11232.0% | −10864.9 |
| Q2 FY2025 | Jun 30, 2025 | -1213.6% | +15066.2 |
| Q1 FY2025 | Mar 31, 2025 | -2159.7% | +4550.8 |
| Q4 FY2024 | Dec 31, 2024 | -147.2% | +1997.6 |
| Q3 FY2024 | Sep 30, 2024 | -367.0% | +275.0 |
| Q2 FY2024 | Jun 30, 2024 | -16279.8% | −15466.7 |
| Q1 FY2024 | Mar 31, 2024 | -6710.5% | −5757.9 |
| Q4 FY2023 | Dec 31, 2023 | -2144.8% | −1671.2 |
| Q3 FY2023 | Sep 30, 2023 | -642.0% | −421.2 |
| Q2 FY2023 | Jun 30, 2023 | -813.1% | −303.0 |
| Q1 FY2023 | Mar 31, 2023 | -952.6% | −916.1 |
| Q3 FY2022 | Sep 30, 2022 | -473.6% | −149.0 |
| Q2 FY2022 | Jun 30, 2022 | -220.8% | +179.6 |
| Q1 FY2022 | Mar 31, 2022 | -510.1% | −30.6 |
| Q4 FY2021 | Dec 31, 2021 | -36.5% | +312.4 |
| Q3 FY2021 | Sep 30, 2021 | -324.6% | −159.0 |
| Q2 FY2021 | Jun 30, 2021 | -400.4% | +619.2 |
| Q1 FY2021 | Mar 31, 2021 | -479.5% | −107.1 |
| Q4 FY2020 | Dec 31, 2020 | -348.9% | −270.5 |
| Q3 FY2020 | Sep 30, 2020 | -165.6% | +138.9 |
| Q2 FY2020 | Jun 30, 2020 | -1019.6% | +51.6 |
| Q1 FY2020 | Mar 31, 2020 | -372.4% | +2263.5 |
| Q4 FY2019 | Dec 31, 2019 | -78.4% | – |
| Q3 FY2019 | Sep 30, 2019 | -304.4% | – |
| Q2 FY2019 | Jun 30, 2019 | -1071.2% | – |
| Q1 FY2019 | Mar 31, 2019 | -2635.9% | – |
See a number that looks wrong?